VTESSE
About Vtesse Vtesse, Inc. is a rare disease company dedicated to developing drugs for patients suffering from diseases that are underserved. The first spin-out company from Cydan Development, Inc., an orphan-drug accelerator that identifies and de-risks programs with therapeutic and commercial potential, Vtesse is working collaboratively with the NIH to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. V... tesse is led by a highly experienced management team that has been involved in the development of more than 20 approved drugs and vaccines. Its experienced consortium of investors, led by New Enterprise Associates, has committed initial funding that is expected to bring this compound through pivotal clinical trials. Vtesse is based in Gaithersburg, Maryland. For more information, visit www.vtessepharma.com.
VTESSE
Industry:
Biotechnology Consumer Research Health Care
Founded:
2014-01-01
Address:
Gaithersburg, Maryland, United States
Country:
United States
Website Url:
http://www.vtessepharma.com
Total Employee:
11+
Status:
Closed
Contact:
(240) 801-9261
Email Addresses:
[email protected]
Total Funding:
42 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Proofpoint
Current Advisors List
Current Employees Featured
Founder
Investors List
Alexandria Venture
Alexandria Venture investment in Series A - Vtesse
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series A - Vtesse
New Enterprise Associates
New Enterprise Associates investment in Series A - Vtesse
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Vtesse
Bay City Capital
Bay City Capital investment in Series A - Vtesse
Lundbeckfonden Ventures
Lundbeckfonden Ventures investment in Series A - Vtesse
New Enterprise Associates
New Enterprise Associates investment in Series A - Vtesse
Pfizer Venture Investments
Pfizer Venture Investments investment in Series A - Vtesse
Bay City Capital
Bay City Capital investment in Series A - Vtesse
Alexandria Venture
Alexandria Venture investment in Series A - Vtesse
Newest Events participated
Participated in Bett Show 2016
on 2016-01-20 as exhibitor
Official Site Inspections
http://www.vtessepharma.com
- Host name: uncoverocular.com
- IP address: 146.214.96.100
- Location: St Louis United States
- Latitude: 38.6249
- Longitude: -90.4496
- Metro Code: 609
- Timezone: America/Chicago
- Postal: 63131
